BTK inhibitor
Term · Oncology and biomedicine · MLC-T-ONC-001283
A substance that blocks the activity of a protein called Bruton tyrosine kinase (BTK), which plays an important role in the development and maturation of B cells. B cells are a type of white blood cell that makes special proteins called antibodies. BTK inhibitors bind to the BTK protein, which is found on most B cells and some types of cancer cells. Blocking BTK may help keep cancer cells from growing. Some BTK inhibitors are used to treat cancer.
| Identifier | MLC-T-ONC-001283 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001283",
"term": "BTK inhibitor",
"field": "Oncology and biomedicine",
"definition": "A substance that blocks the activity of a protein called Bruton tyrosine kinase (BTK), which plays an important role in the development and maturation of B cells. B cells are a type of white blood cell that makes special proteins called antibodies. BTK inhibitors bind to the BTK protein, which is found on most B cells and some types of cancer cells. Blocking BTK may help keep cancer cells from growing. Some BTK inhibitors are used to treat cancer.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/btk-inhibitor/"
}
Record 3,916 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.